C643 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Head-Neck cancer cell lines

Organism

Human

Donor History

Anaplastic thyroid carcinoma

Growth Properties

Monolayer

,

adherent

Growth Conditions

Culture medium: RPMI 1640

,

w: 2.0 mM stable Glutamine

,

w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Seeding density: 1 x 10⁴ cells/cm² will yield in a confluent layer in about 3 days. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/C643-Cells/300298

SKU: 300298 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The cell line C643 was established from a fine-needle biopsy of an anaplastic thyroid carcinoma of a 76-year-old man by Mark et al. in 1987. The patient died within 5 months after diagnosis. Demonstration of thyroglobulin mRNA ascertained a thyroid epithelial origin of the cell line. C643 cells emerge as a valuable tool for thyroid cancer research.
These cells originated from human thyroid cancer tissue and represented metastatic PTC, FTC, and ATC. Their genetic makeup reflects the common mutations observed in thyroid cancer, such as alterations in BRAF, RAS, and PI3K genes, which activate critical signalling pathways.
This makes C643 cells an ideal model for investigating the mechanisms involved in thyroid cancer development and progression. Furthermore, C643 cells are a crucial resource for testing potential targeted therapies.
Their inclusion in preclinical studies can aid in identifying and evaluating novel compounds that specifically target the altered signalling pathways implicated in thyroid cancer. By accurately representing human thyroid cancer, C643 cells contribute to developing more effective treatments for patients with advanced thyroid cancer.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.